The Perils of Pull-Through

Listen on: Apple Podcasts or Spotify
In this episode of the IDI Podcast, Jack Timko, Senior Principal, Valuate Health Consultancy, discusses the perils of pull-through in market access and shares how data may be the answer.
Listen on: Apple Podcasts or Spotify
Archbow Consulting, Entrée Health, and Valuate Health Consultancy are sister companies under the Value and Access division of Omnicom Health Group. Learn more about our united organizations here.
For additional insights on this topic, you may also enjoy the following:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
CMS BFSF Rule: Critical Changes Every Pharma Company Must Address
Manufacturers must now submit ASP data with FMV documentation and BFSF fee certification for Medicare Part B drugs.
Self-Injection Training & Patient Success
Practical, hands-on self-injection training plays a pivotal role in ensuring proper medication use and driving positive patient outcomes.
Navigating Pharmacy Types for Commercialization Success
The pharmaceutical market is evolving fast, and delivering prescriptions efficiently is more challenging than ever. The right pharmacy dispensing strategy can be the difference maker between commercial success and missed opportunities.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|


